Internal Medicine, Gastroenterology · Tupelo, MS
NPI
1366477390
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
589 Garfield St Ste 201
Tupelo, MS, 38801
Phone (662) 680-5565
Groups this clinician bills Medicare through
Medicare paid, 2024
$188K
5,688 services
Medicare patients, 2024
696
Average age 72
Drug cost, 2024
$765K
1,550 prescriptions
Company payments, 2025
$143
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John B Averette was code 99214 (office e&m - established), 235 times for 176 patients. In total John B Averette billed 5,688 services in 52 codes, and Medicare paid $188K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 235 | 176 | $84.56 | $20K |
| 43239 Upper GI Endoscopy | Facility | 108 | 107 | $88.32 | $9,539 |
| 45385 Colonoscopy - Lesion Removal | Facility | 97 | 97 | $200.45 | $19K |
| 99204 Office E&M - New | Office | 96 | 96 | $112.57 | $11K |
| 45380 Lower GI Endoscopy - Other | Facility | 92 | 92 | $104.04 | $9,572 |
| 99221 Hospital E&M - Initial | Facility | 89 | 88 | $65.49 | $5,829 |
| 99232 Hospital E&M - Subsequent | Facility | 69 | 44 | $61.65 | $4,254 |
| 43235 Upper GI Endoscopy | Facility | 48 | 48 | $80.33 | $3,856 |
| 99213 Office E&M - Established | Office | 40 | 39 | $58.16 | $2,326 |
| 99203 Office E&M - New | Office | 38 | 38 | $60.22 | $2,288 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 36 | 36 | $170.96 | $6,155 |
| 45378 Lower GI Endoscopy - Other | Facility | 36 | 36 | $127.26 | $4,581 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 32 | 32 | $179.69 | $5,750 |
| 43450 Digestive/Gastrointestinal | Facility | 28 | 28 | $29.14 | $816 |
| 91110 Standard X-ray | Office | 24 | 23 | $527.07 | $13K |
By year: 2022 $308K for 10,783 services; 2023 $289K for 12,346 services; 2024 $188K for 5,688 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85027 Blood Count | 19 | 19 | $6.40 | $122 |
| 80076 Clinical Chemistry | 14 | 13 | $8.09 | $113 |
Medicare prescription drug claims, 2024
In 2024, the drug John B Averette prescribed most often to Medicare patients was Pantoprazole Sodium, with 248 prescriptions and refills. In total John B Averette wrote 1,550 Medicare prescriptions that cost $765K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 248 | 522 | 76 | $2,189 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 203 | 203 | 200 | $13K |
| Dicyclomine Hcl Generic | 198 | 260 | 65 | $3,305 |
| Omeprazole Generic | 99 | 219 | 31 | $1,088 |
| Famotidine Generic | 91 | 177 | 24 | $1,093 |
| Metoclopramide Hcl Generic | 84 | 144 | 25 | $388 |
| Linzess Linaclotide | 55 | 92 | 18 | $49K |
| Esomeprazole Magnesium Generic | 41 | 65 | 11 | $967 |
| Cholestyramine Cholestyramine (With Sugar) | 37 | 47 | 15 | $1,738 |
| Ondansetron Hcl Generic | 35 | 37 | 14 | $259 |
| Budesonide Dr Budesonide | 26 | 36 | Under 11 | $2,904 |
| Methscopolamine Bromide Generic | 24 | 30 | Under 11 | $3,930 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 24 | 24 | 22 | $357 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 20 | 20 | 20 | $381 |
| Stelara Ustekinumab | 19 | 33 | Under 11 | $533K |
Brand drugs: 281 claims; generic drugs: 1,269 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John B Averette $143 ($143 in general payments such as food, travel and fees) from 7 companies. The largest payer was Abbvie Inc. with $37.81.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.